Abstract
The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
Original language | English |
---|---|
Pages (from-to) | 582-583 |
Number of pages | 2 |
Journal | American Journal of Cardiology |
Volume | 92 |
Issue number | 5 |
DOIs | |
State | Published - Aug 22 2003 |
Bibliographical note
Funding Information:TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.
Funding
TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.
Funders | Funder number |
---|---|
Merck |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine